Skip to main content
Log in

PP13 mRNA Expression in Trophoblasts From Preeclamptic Placentas

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

To assess the role of placental protein 13 (PP13) in the pathogenesis of preeclampsia, the messenger RNA expression of PP13 was investigated in the trophoblasts from first and third trimester placenta. First, syncytiotrophoblasts and extravillous trophoblasts were separated from frozen section of third trimester placenta obtained from pregnant women with and without preeclampsia by laser microdissection. The PP13 levels of syncytiotrophoblasts were significantly higher than those of extravillous trophoblasts. The expression levels in syncytiotrophoblasts from the preeclampsia were significantly lower than those from normal. Next, the PP13 expression was assessed in trophoblasts from residual samples of chorionic villus sampling at 11 weeks of gestation, who subsequently developed preeclampsia. The levels in the preeclampsia group were significantly lower than those of normal cases. These findings indicate that an alteration in the PP13-messenger RNA expression in the trophoblasts may be associated with the pathogenesis of preeclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799.

    Article  Google Scholar 

  2. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594.

    Article  CAS  Google Scholar 

  3. Dugoff L, Lynch AM, Cioffi-Ragan D, et al. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet Gynecol. 2005;193:1208–1212.

    Article  Google Scholar 

  4. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191:1446–1451.

    Article  CAS  Google Scholar 

  5. Than NG, Romero R, Hillermann R, Cozzi V, Nie G, Huppertz B. Prediction of preeclampsia—a workshop report. Placenta. 2008;29 (suppl A):S83–S85.

  6. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:133–137.

    Article  CAS  Google Scholar 

  7. Chafetz I, Kuhnreich I, Sammar M, et al. First-trimester pla-cental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2007;197:35 e1–e7.

    Article  Google Scholar 

  8. Romero R, Kusanovic JP, Than NG, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol. 2008;199:122.e1–122.e11.

    Article  Google Scholar 

  9. Burger O, Pick E, Zwickel J, et al. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta. 2004;25:608–622.

    Article  CAS  Google Scholar 

  10. Than NG, Bohn H, Toth P, Bersinger N, Grudzinskas JG, Bischof P. From basic research to clinical application of placental proteins—a workshop report. Placenta. 2004;25 (suppl A):S109–S111.

  11. Than NG, Pick E, Bellyei S, et al. Functional analyses of placen-tal protein 13/galectin–13. Eur J Biochem. 2004;271:1065–1078.

    Article  CAS  Google Scholar 

  12. Yamamoto G, Irie T, Aida T, Nagoshi Y, Tsuchiya R, Tachikawa T. Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma. Virchows Arch. 2006;448:435–441.

    Article  CAS  Google Scholar 

  13. Purwosunu Y, Sekizawa A, Farina A, et al. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors. Am J Obstet Gynecol. 2008;198:124 e1–e7.

    Article  Google Scholar 

  14. Purwosunu Y, Sekizawa A, Koide K, et al. Cell-free mRNA concentrations of plasminogen activator inhibitor–1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clin Chem. 2007;53:399–404.

    Article  CAS  Google Scholar 

  15. Silver RK, Wilson RD, Philip J, et al. Late first-trimester pla-cental disruption and subsequent gestational hypertension/ preeclampsia. Obstet Gynecol. 2005;105:587–592.

    Article  Google Scholar 

  16. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80:283–285.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akihiko Sekizawa MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sekizawa, A., Purwosunu, Y., Yoshimura, S. et al. PP13 mRNA Expression in Trophoblasts From Preeclamptic Placentas. Reprod. Sci. 16, 408–413 (2009). https://doi.org/10.1177/1933719108328615

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719108328615

Key words

Navigation